Transcriptomics

Dataset Information

0

The HDAC inhibitor Panobinostat (LBH589) exerts in vivo anti-leukaemic activity against in MLL-rearranged Acute Lymphoblastic Leukaemia and involves the RNF20/RNF40/WAC – H2B ubiquitination axis


ABSTRACT: We demonstrate the in vivo efficacy of the histone deacetylase inhibitor Panobinostat (LHB589) against MLL-rearranged ALL using xenograft mouse models of MLL-rearranged ALL cell lines and primary patient cells. Panobinostat monotherapy showed strong anti-leukaemic effects, extending survival and reducing overall disease burden. Comprehensive molecular analyses in vitro showed the anti-leukaemic activity in MLL-rearranged ALL to involve depletion of H2B ubiquitination via suppression of the RNF20/RNF40/WAC E3 ligase complex.

ORGANISM(S): Homo sapiens

PROVIDER: GSE78234 | GEO | 2017/07/12

SECONDARY ACCESSION(S): PRJNA312966

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-12-17 | GSE66475 | GEO
2015-12-17 | E-GEOD-66475 | biostudies-arrayexpress
| PRJNA312966 | ENA
2008-11-20 | E-MEXP-1911 | biostudies-arrayexpress
2025-12-04 | GSE222089 | GEO
2021-04-05 | GSE166409 | GEO
2025-12-04 | GSE221490 | GEO
2024-06-01 | GSE264597 | GEO
2022-08-06 | GSE210425 | GEO
2021-02-24 | GSE135628 | GEO